The National Kidney Foundation (NKF) has awarded Jayme Locke, MD, MPH, FACS, FAST, Vice President, Medical Development, ...
Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide ...
Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...
M.D., Ph.D., President and Chief Executive Officer of Black Diamond Therapeutics. “Servier’s commitment to innovation and deep expertise in oncology make it an ideal partner for Black Diamond as we ...
M.D., Ph.D., President and Chief Executive Officer of Black Diamond Therapeutics. "Servier's commitment to innovation and deep expertise in oncology make it an ideal partner for Black Diamond as we ...
M.D., Ph.D., President and Chief Executive Officer of Black Diamond Therapeutics. “Servier’s commitment to innovation and deep expertise in oncology make it an ideal partner for Black Diamond ...
Life Sciences announced today that it is building on OFD's 60 plus years of lyophilization expertise with multiple leadership appointments to its recently created Life Sciences division and the ...
Moon Surgical, a French-American pioneer in surgical innovation, announced today the United States Food and Drug ...
The drug is approved in some countries, including the United States, for UC. Building on data from the ... Ailsa Hart, MD, director, IBD Research, and consultant gastroenterologist, St. Mark ...